Can MRI predict the diagnosis of endometrial carcinosarcoma?

Clinical Radiology

Volumn 66, Issue 7, 2011, Pages 621-624

  Genever, A V ^a   Abdi, S ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTERIOR POSTERIOR AXIS; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CARCINOSARCOMA; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UTERUS;

EID: 79957784753     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2011.02.008     Document Type: Article

References (25)

1. Sutton G, Kauderer J, Carson L, et al. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumours) of the uterus: a Gynecological Oncology Group study. Gynecologic Oncology 2005;96:630-4. (Pubitemid 40255480)
2. Smith T, Moy L, Runowicz C. Mullerian mixed tumors. CT characteristics with clinical and pathological observations. AJR Am J Roentgenol 1997;169:531-5.
3. Kato H, Kanematsu M, Furui, et al. Carcinosarcoma of the uterus: radiologic - pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging. Magn Reson Imaging 2008;26:1446-50.
4. Rha S, Byun J, Jung S, et al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003;181:1369-74. (Pubitemid 37296418)
5. Galaal K, Kew F, Tam K, et al. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma. Eur J Obstet Gynecol Reprod Biol 2009;143:88-92.
6. Bosquet J, Terstriep S, Cliby W, et al. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol 2010;116:419-23.
7. SpanosW, Wharton J, Gomez L, et al. Malignant mixed Mullerian tumors of the uterus. Cancer 1984;53:311-6. (Pubitemid 14180747)
8. Iwasa Y, Haga H, Konishi I, et al. Prognostic factors in uterine carcinosarcoma. Cancer 1998;82:512-9.
9. Nordal R, Kristensen G, Stenwig A, et al. An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol 1997;67:316-21. (Pubitemid 28034640)
10. Sartori E, Bazzurini L, Gadducci A, et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol 1997;67:70-5. (Pubitemid 27433331)
11. Krivak T, Seidman J, McBroom J, et al. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol. Oncol 2001;83:89-94. (Pubitemid 32959883)
12. Leath C, Numnum T, Kendrick J, et al. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma. Int J Gynecol Cancer 2009;19:888-91.
13. Major F, Blessing J, Silverberg S, et al. Prognostic factors in early-stage uterine sarcoma. Cancer Suppl 1993;71:1702-9.
14. Bansal N, Herzog T, Brunner-Brown A, et al. The utility and cost-effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol 2008;111:208-12.
15. Nugent E, Zighelboim I, Case A, et al. The value of perioperative imaging in patients with uterine sarcomas. Gynecol Oncol 2009;115:37-40.
16. Yoshinaga M, Togami S, Tsuji T, et al. Clinical outcome of metastatic uterine leiomyosarcoma and carcinosarcoma in a single institute. J Obstet Gynaecol Res 2007;33:818-22. (Pubitemid 350086514)
17. Moskovic E, Macsweeney E, Law M, et al. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol 1993;66:1009-15. (Pubitemid 23337083)
18. Ohguri T, Aoki T, Watanabe H, et al. MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol 2002;12:2737-42. (Pubitemid 36940387)
19. Takeuchi M, Matsuzaki K, Uehara H, et al. Pathologies of the uterine endometrial cavity: usual and unusual manifestations and pitfalls on magnetic resonance imaging. Eur Radiol 2005;15:2244-55. (Pubitemid 41600109)
20. Shapeero L, Hricak H. Mixed Mullerian sarcoma of the uterus: MR imaging findings. AJR Am J Roentgenol 1989;153:317-9. (Pubitemid 19198014)
21. Sahdev A, Sohaib S, Jacobs I, et al. MR imaging of uterine sarcomas. AJR Am J Roentgenol 2001;177:1307-11. (Pubitemid 33081470)
22. Marchese M, Liskow A, Crum C, et al. Uterine sarcomas: a clinicopathological study, 1965-1981. Gynecol Oncol 1984;18:299-312.
23. Wolfson A, Brady M, Rocereto T, et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage IeIV carcinosarcoma (CS) of the uterus. Gynecol Oncol 2007;107:177-85. (Pubitemid 47575740)
24. Umesaki N, Tanaka T, Miyama M, et al. Combined diagnostic imaging of uterine carcinosarcoma: a case report. Int J Gynecol Cancer 2000;10:425-8.
25. Umesaki N, Tanaka T, Miyama M, et al. Positron emission tomography with 18F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 2001;80:372-7. (Pubitemid 32207538)